1-16 of 16
Michael L. Maitland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Free
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Y. Jin, Michael L. Maitland, Martin Reck, Mark A. Socinski
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (20): 4314.
https://doi.org/10.1158/1078-0432.CCR-23-2525
Published: 13 October 2023
View articletitled, Correction: Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150
Open the PDF for Correction: Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150 in another window
Journal Articles

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Available to Purchase
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Y. Jin, Michael L. Maitland, Martin Reck, Mark A. Socinski
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (6): 1047–1055.
https://doi.org/10.1158/1078-0432.CCR-22-2323
Published: 14 March 2023
View articletitled, Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150
Open the PDF for Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150 in another window
Includes: Supplementary data
Journal Articles

First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors

Open Access
Michael L. Maitland, Jasgit C. Sachdev, Manish R. Sharma, Victor Moreno, Valentina Boni, Shivaani Kummar, Erica Stringer-Reasor, Nehal Lakhani, Allison R. Moreau, Dawei Xuan, Ray Li, Eric L. Powell, Amy Jackson-Fisher, Michelle Bowers, Shilpa Alekar, Xiaohua Xin, Anthony W. Tolcher, Emiliano Calvo
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4511–4520.
https://doi.org/10.1158/1078-0432.CCR-20-3757
Published: 15 August 2021
View articletitled, First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
Open the PDF for First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract PO022: Multidimensional longitudinal assessment of patients under treatment for advanced endometrial cancer: a new tool to advance research on human disease

Free
Erik Dvergsten, Sanja Karovic, Vasiliki Thomeas-McEwing, Danielle Kimble, Pingzhen Guo, Hao Yang, Binsheng Zhao, Lawrence H. Schwartz, Michael L. Maitland
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3_Supplement): PO022.
https://doi.org/10.1158/1557-3265.ENDOMET20-PO022
Published: 01 February 2021
View articletitled, Abstract PO022: Multidimensional longitudinal assessment of patients under treatment for advanced endometrial cancer: a new tool to advance research on human disease
Journal Articles

Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation

Available to Purchase
Michael L. Maitland, Julia Wilkerson, Sanja Karovic, Binsheng Zhao, Jessica Flynn, Mengxi Zhou, Patrick Hilden, Firas S. Ahmed, Laurent Dercle, Chaya S. Moskowitz, Ying Tang, Dana E. Connors, Stacey J. Adam, Gary Kelloff, Mithat Gonen, Tito Fojo, Lawrence H. Schwartz, Geoffrey R. Oxnard
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (24): 6464–6474.
https://doi.org/10.1158/1078-0432.CCR-20-1493
Published: 15 December 2020
View articletitled, Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation
Open the PDF for Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation in another window
Includes: Supplementary data
Journal Articles

Cancer Clinical Investigators Should Converge with Pharmacometricians

Available to Purchase
Michael L. Maitland, Roisin E. O'Cearbhaill, Jogarao Gobburu
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (17): 5182–5184.
https://doi.org/10.1158/1078-0432.CCR-19-1067
Published: 03 September 2019
View articletitled, Cancer Clinical Investigators Should Converge with Pharmacometricians
Open the PDF for Cancer Clinical Investigators Should Converge with Pharmacometricians in another window
Journal Articles

Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide

Available to Purchase
Peter H. O'Donnell, Sanja Karovic, Theodore G. Karrison, Linda Janisch, Matthew R. Levine, Pamela J. Harris, Blase N. Polite, Ezra E.W. Cohen, Gini F. Fleming, Mark J. Ratain, Michael L. Maitland
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5092–5099.
https://doi.org/10.1158/1078-0432.CCR-15-0427
Published: 12 November 2015
View articletitled, Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide
Open the PDF for Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide in another window
Includes: Supplementary data
Journal Articles

Identification of a Variant in KDR Associated with Serum VEGFR2 and Pharmacodynamics of Pazopanib

Available to Purchase
Michael L. Maitland, Chun-Fang Xu, Yu-Ching Cheng, Emily Kistner-Griffin, Kathleen A. Ryan, Theodore G. Karrison, Soma Das, Dara Torgerson, Eric R. Gamazon, Vasiliki Thomeas, Matthew R. Levine, Paul A. Wilson, Nan Bing, Yuan Liu, Lon R. Cardon, Lini N. Pandite, Jeffrey R. O'Connell, Nancy J. Cox, Braxton D. Mitchell, Mark J. Ratain, Alan R. Shuldiner
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 365–372.
https://doi.org/10.1158/1078-0432.CCR-14-1683
Published: 14 January 2015
View articletitled, Identification of a Variant in KDR Associated with Serum VEGFR2 and Pharmacodynamics of Pazopanib
Open the PDF for Identification of a Variant in KDR Associated with Serum VEGFR2 and Pharmacodynamics of Pazopanib in another window
Includes: Supplementary data
Journal Articles

Stepwise development of biomarkers for angiogenic activity with standardized assays for circulating molecules in human subjects

Free
Michael L. Maitland, Emily Kistner, Larry House, Theodore Karrison, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): B84.
Published: 15 August 2014
View articletitled, Stepwise development of biomarkers for angiogenic activity with standardized assays for circulating molecules in human subjects
Journal Articles

Evaluation of Food Effect on Pharmacokinetics of Vismodegib in Advanced Solid Tumor Patients

Available to Purchase
Manish R. Sharma, Theodore G. Karrison, Bethany Kell, Kehua Wu, Michelle Turcich, David Geary, Soonmo P. Kang, Naoko Takebe, Richard A. Graham, Michael L. Maitland, Richard L. Schilsky, Mark J. Ratain, Ezra E.W. Cohen
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 3059–3067.
https://doi.org/10.1158/1078-0432.CCR-12-3829
Published: 30 May 2013
View articletitled, Evaluation of Food Effect on Pharmacokinetics of Vismodegib in Advanced Solid Tumor Patients
Open the PDF for Evaluation of Food Effect on Pharmacokinetics of Vismodegib in Advanced Solid Tumor Patients in another window
Journal Articles

Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients

Available to Purchase
Ezra E.W. Cohen, Kehua Wu, Christine Hartford, Masha Kocherginsky, Kimberly Napoli Eaton, Yuanyuan Zha, Anitha Nallari, Michael L. Maitland, Kammi Fox-Kay, Kristin Moshier, Larry House, Jacqueline Ramirez, Samir D. Undevia, Gini F. Fleming, Thomas F. Gajewski, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (17): 4785–4793.
https://doi.org/10.1158/1078-0432.CCR-12-0110
Published: 30 August 2012
View articletitled, Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients
Open the PDF for Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Resampling Phase III Data to Assess Phase II Trial Designs and Endpoints

Available to Purchase
Manish R. Sharma, Theodore G. Karrison, Yuyan Jin, Robert R. Bies, Michael L. Maitland, Walter M. Stadler, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (8): 2309–2315.
https://doi.org/10.1158/1078-0432.CCR-11-1815
Published: 16 April 2012
View articletitled, Resampling Phase III Data to Assess Phase II Trial Designs and Endpoints
Open the PDF for Resampling Phase III Data to Assess Phase II Trial Designs and Endpoints in another window
Includes: Supplementary data
Journal Articles

Two Drug Interaction Studies of Sirolimus in Combination with Sorafenib or Sunitinib in Patients with Advanced Malignancies

Available to Purchase
Tara C. Gangadhar, Ezra E.W. Cohen, Kehua Wu, Linda Janisch, David Geary, Masha Kocherginsky, Larry K. House, Jackie Ramirez, Samir D. Undevia, Michael L. Maitland, Gini F. Fleming, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1956–1963.
https://doi.org/10.1158/1078-0432.CCR-10-2061
Published: 31 March 2011
View articletitled, Two Drug Interaction Studies of Sirolimus in Combination with Sorafenib or Sunitinib in Patients with Advanced Malignancies
Open the PDF for Two Drug Interaction Studies of Sirolimus in Combination with Sorafenib or Sunitinib in Patients with Advanced Malignancies in another window
Journal Articles

Analysis of the Yield of Phase II Combination Therapy Trials in Medical Oncology

Available to Purchase
Michael L. Maitland, Christine Hudoba, Kelly L. Snider, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5296–5302.
https://doi.org/10.1158/1078-0432.CCR-10-0669
Published: 31 October 2010
View articletitled, Analysis of the Yield of Phase II Combination Therapy Trials in Medical Oncology
Open the PDF for Analysis of the Yield of Phase II Combination Therapy Trials in Medical Oncology in another window
Journal Articles

Volumes to Learn: Advancing Therapeutics with Innovative Computed Tomography Image Data Analysis

Available to Purchase
Michael L. Maitland
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (18): 4493–4495.
https://doi.org/10.1158/1078-0432.CCR-10-1548
Published: 14 September 2010
View articletitled, Volumes to Learn: Advancing Therapeutics with Innovative Computed Tomography Image Data Analysis
Open the PDF for Volumes to Learn: Advancing Therapeutics with Innovative Computed Tomography Image Data Analysis in another window
Includes: Supplementary data
Journal Articles

Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment

Available to Purchase
Michael L. Maitland, Kristen E. Kasza, Theodore Karrison, Kristin Moshier, Laura Sit, Henry R. Black, Samir D. Undevia, Walter M. Stadler, William J. Elliott, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6250–6257.
https://doi.org/10.1158/1078-0432.CCR-09-0058
Published: 30 September 2009
View articletitled, Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
Open the PDF for Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment in another window
Includes: Supplementary data